- Home
- YSXT vs IXHL Comparison
YSXT vs IXHL Comparison
Compare YSXT & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | YSXT | IXHL |
|---|---|---|
| Founded | 2011 | 2001 |
| Country | China | Australia |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.6M | 49.1M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | YSXT | IXHL |
|---|---|---|
| Price | $2.27 | $0.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 594.7K | ★ 23.0M |
| Earning Date | 07-31-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $71,452,736.00 | $12,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.70 | ★ N/A |
| Revenue Growth | ★ 22.04 | N/A |
| 52 Week Low | $1.68 | $0.08 |
| 52 Week High | $9.96 | $2.25 |
Technical Indicators
Market Signals| Indicator | YSXT | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 48.54 | 65.35 |
| Support Level | $2.02 | $0.35 |
| Resistance Level | $2.38 | $0.50 |
| Average True Range (ATR) | 0.28 | 0.03 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 34.78 | 82.82 |
Price Performance
Historical ComparisonAbout YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.